David Khougazian new CEO of Chiesi
The new CEO of the Parma-based group will take office on October 15th, taking over from Jean-Marc Bellemin, who will continue in the role of CFO.
Chiesi has appointed David Khougazian as its new CEO, effective October 15, succeeding Jean-Marc Bellemin who will become CFO. Khougazian brings over 25 years of experience in the healthcare industry, previously working at Flagship Pioneering, Sanofi, and Aventis. The appointment comes as Chiesi accelerates its research, rare disease, and US expansion efforts. In the first half of 2024, Chiesi reported revenues of €1.89 billion, up 3.6%, with rare diseases and US sales growing 9.9% and 9.6% respectively.
Written by urgent.news from Il Sole 24 Ore's report — not a translation of it. Machine-written — may contain errors; check the original before relying on it.
